Although A3H Hap I has been implicated in lung cancer [5,173,174], this study stated that similar to A3B, overexpression of A3A, but not A3H, predicts poor NSCLC prognosis (figure 4) [133]. Here, APOBEC3H is linked to lung carcinoma.